Latest news with #dental
Yahoo
40 minutes ago
- Business
- Yahoo
ZimVie to Be Taken Private by Archimed in $730 Million Buyout Deal
ZimVie (ZIMV) shares surged intraday Monday after the dental implant company agreed to be acquired a
Yahoo
15 hours ago
- Business
- Yahoo
Arini Appoints Eric Johnson as Chief Commercial Officer to Accelerate Enterprise AI Adoption in the Dental Industry
SAN FRANCISCO, July 23, 2025 /PRNewswire/ -- Arini, the AI-native infrastructure for Dental Service Organizations (DSOs), today announced the appointment of Eric Johnson as Chief Commercial Officer (CCO). Eric brings more than a decade of proven leadership in the dental industry, including most recently as Founder & CEO of Membersy, the nation's largest dental membership plan platform. As CCO, Eric will lead Arini's go-to-market strategy and enterprise partnerships, working closely with DSO clients to help deploy scalable, AI-powered solutions to optimize patient engagement, streamline administrative tasks, and automate operational workflows. His appointment marks a strategic milestone for Arini as it rapidly expands its enterprise value proposition — a highly custom AI strategy-to-execution offering — designed to meet the unique needs of dental enterprises, practices, and teams. "Eric is one of the most respected entrepreneurs in dentistry," said Abdul Jamjoom, CEO of Arini. "He deeply understands the dental ecosystem, and brings authentic relationships and credibility from across the industry with him from day one. Eric's decision to join Arini underscores the strength of our vision and signals to the market that we're uniquely positioned to deliver AI at scale for our clients." Backed by Y Combinator and founded by experienced engineers from Harvard & MIT, Arini debuted last year with the Arini AI Receptionist, the industry's first truly AI-powered patient engagement platform. Building on that foundation, Arini is now expanding into a full-service AI Transformation Partner for DSOs — offering AI Strategy & Consulting, Forward Deployed Engineers, and timely Technology Delivery. "With AI reshaping every corner of healthcare, I'm excited to join Arini and help lead its mission to bring impactful AI to the dental industry," said Eric Johnson, Chief Commercial Officer at Arini. "What drew me to Arini was not only the strength of the team and the clarity of the mission, but also the thoughtful approach to AI — one that enhances, not replaces, the human element of care and operations." About Arini Arini is a full-service AI Transformation Partner for growing dental enterprises, practices, and teams. We bring together deep domain expertise and the best AI-native engineering talent for our clients as they constantly reinvent their business operations and patient interactions with the application of advanced AI. From our flagship AI Receptionist that handles 10,000+ calls daily to our forward-deployed teams and systems, we're on a mission to deliver practical, scalable AI solutions for the dental industry. Learn more at View original content to download multimedia: SOURCE Arini Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Business
- Yahoo
Dentsply Sirona (XRAY) Stock Is Up, What You Need To Know
What Happened? Shares of dental products company Dentsply Sirona (NASDAQ:XRAY) jumped 3.5% in the morning session after the company announced the appointment of a new CEO, released positive preliminary second-quarter results, and reaffirmed its full-year 2025 financial outlook. The company named Daniel Scavilla, a current board member and former CEO of Globus Medical, as its new President and CEO, effective August 1, 2025. Scavilla brings decades of experience in the medical technology and pharmaceutical sectors. Alongside the leadership change, Dentsply Sirona provided an encouraging financial update. It expects second-quarter net sales of approximately $935 million and adjusted earnings per share (EPS) between $0.50 and $0.52. This compares favorably to consensus estimates of $931.3 million in revenue and an EPS of $0.497. The company also confirmed its 2025 guidance, signaling confidence in its strategic direction. The positive news was compounded by M&A activity in the dental sector, as competitor ZimVie announced it would be acquired by investment firm ARCHIMED at a significant premium. After the initial pop the shares cooled down to $15.95, up 1.7% from previous close. Is now the time to buy Dentsply Sirona? Access our full analysis report here, it's free. What Is The Market Telling Us Dentsply Sirona's shares are not very volatile and have only had 9 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business. The biggest move we wrote about over the last year was 2 months ago when the stock gained 6% on the news that the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains. However, President Trump clarified that tariffs could go "substantially higher" if a full deal with China wasn't reached during the 90-day pause, but not all the way back to the previous levels. Still, the agreement cooled fears of a prolonged trade war, helping stabilize expectations for global growth and trade flows and fueled renewed optimism. The optimism appeared concentrated in key trade-sensitive sectors, particularly technology, retail, and industrials, as lower tariffs reduce cost pressures and restore cross-border demand. Dentsply Sirona is down 14.9% since the beginning of the year, and at $15.95 per share, it is trading 41.2% below its 52-week high of $27.14 from July 2024. Investors who bought $1,000 worth of Dentsply Sirona's shares 5 years ago would now be looking at an investment worth $363.75. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Business
- Yahoo
ZimVie to Be Taken Private by Archimed in $730 Million Buyout Deal
ZimVie (ZIMV) shares surged intraday Monday after the dental implant company agreed to be acquired a Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
BreakingNews.ie
6 days ago
- Health
- BreakingNews.ie
More than 90% of childrens' general health ‘good or very good'
The general health of more than 90 per cent of children in Ireland aged two to 17 years was considered to be good or very good last year, new research shows. The Central Statistics Office (CSO) has published the Irish Health Survey – Children's Health for 2024. Advertisement The research also found that the general dental health of over four in five children aged two to 17 years was considered to be 'good or very good', while 3.2 per cent were considered to have 'bad or very bad' general dental health. The general health of over 90% of children aged 2 to 17 years was considered to be good or very good in 2024 #CSOIreland #Ireland #Health #HSE #IrishHealthSurvey @CoruIreland @HealthyIreland @HSELive @HSEQuitTeam — Central Statistics Office Ireland (@CSOIreland) July 18, 2025 Approximately 5.6 per cent of children aged two to 17 years were admitted to a hospital as an in-patient and 14.7 per cent were admitted as a day-case patient in the past 12 months. More than half of children aged two to 17 years had taken prescription medicine, non-prescription medicine or vitamins in the two weeks prior to interview. The survey also shows that prescription medicine was taken by 18.7 per cent of children aged two to 17 years and non-prescription medicine or vitamins were taken by 41.9 per cent of children. Advertisement Almost half of children aged two to 17 years needed a medical examination or treatment, excluding dental, for a health problem in the past 12 months. More than 91 per cent of children aged two to eight years were more likely to eat fruits and vegetables at least once a day, compared with children aged 13 to 17 years at 84.3 per cent. Participation in leisure activities such as swimming, playing an instrument, or youth organisations was highest for those aged nine to 12 years at 92.3% and lowest for those aged two to eight years at 80.8 per cent. The percentage of children aged two to 17 years who were considered to be in 'good or very good' health was highest in HSE south west at 95.2% and lowest in HSE Dublin and midlands at 90.8%. Advertisement The percentage of children aged two to 17 years with a long-standing illness or health problem was higher for boys at 19.9% than girls at 16.8%. A child's long-standing illness or health problem refers to illnesses or health problems which have lasted, or are expected to last, for six months or more. The main characteristics of a long-standing illness or chronic condition is that it is permanent and may be expected to require a long period of supervision, observation, or care. Health problems cover different physical, emotional, behavioural, and mental dimensions of health. Advertisement Ireland Harris brings up SuperValu mistake after Doherty's... Read More Besides diseases and disorders, they can also include pain, ill-health caused by accidents and injuries, and congenital conditions. Sarah Crilly, statistician in the Health and Social Cohesion Division said: 'The statistics contained in this release are selected from a module on children's health that was included in the Irish Health Survey, which was conducted in 2024. 'The guardians of children aged between two to 17 years were asked questions, via an online questionnaire, about their child's health status, access to health care, and their health determinants such as nutrition and recreational activities.'
